About Timothy Cannon, MD
Dr. Cannon is a specialty care physician board certified in medical oncology. He joins Inova Medical Group with over 6 years of clinical experience in oncology. He has a special interest in management of gastrointestinal malignancies.
Dr. Cannon is the clinical director and moderator of the weekly molecular tumor board at Inova, which matches patients with targeted therapies based on molecular diagnostics. He is very interested in national cooperative group clinical trials and is a member of the NRG colorectal and non-colorectal clinical trials committee. He is the site principal investigator for multiple clinical trials in immunotherapy.
Dr. Cannon was the chief fellow of hematology/oncology at New York University (NYU). He was voted fellow of the year at NYU during each of his last 2 years there. He received a “best doctor” award by Northern Virginia magazine in 2015.
A native of New Jersey, Dr. Cannon is married with 2 sons. His wife, Amy, works for Save the Children. In his spare time, he likes to play sports (particularly soccer, flag football, tennis) and read books. He was a member of two Division I basketball teams (University of Utah as a freshman and then later at Brigham Young University) in the 1990s and continues to be a huge basketball fan.
- Assistant Professor, Department of Medicine, Virginia Commonwealth University
- NYU Chief Fellow of Hematology/Oncology 2010-2011
- NYU Fellow of the Year 2011
- NYU Fellow of the Year 2010
- American Society of Clinical Oncology
Research & Publications
The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer. 2016. CannonT., Ford J., Hester D., Trump D.
Utah Roots … and Herbs. Journal of Clinical Oncology. 2015. Timothy L. Cannon.
RAS Mutations Beyond Exon 2: A Review and Discussion of Clinical Trial Data. Current Treatment Options in Oncology. 2015 Jul:16(7):350. Cannon TL, Kokon MA, Shafqat S, Deeken JF.
Exanetide and Pancreatic Cancer: A Case Report and Review of Relevant Literature. American Journal of Cancer Case Reports. 2015;3:124-132. Cannon TL, Atkins MB, Deeken JF, et al.
Squamous Cell Carcinoma of the Oral Cavity in Nonsmoking Women A New and Unusual Complication of Chemotherapy for Recurrent Ovarian Cancer? The Oncologis.2012; 17: 1541-1546. Cannon TL., Lai DW., Hirsch D et al.
Mutiple Cases of Squamous Cell Carcinoma of the Tongue and Oral Cavitiy in Patients treated with long-term Pegylated Liposomal Doxorubicin (PLD) for Ovarian Cancer. The Journal of Clinical Oncology. 29: 2011 (suppl; abstr 5557). Cannon TL., Muggia F., Hirsch D et al.
Delayed Neoplastic and Renal Complications in Women Receiving Long-term Chemotherapy for Recurrent Ovarian Cancer. The Journal of The National Cancer Institute (JNCI). 2011; 103(2): 160-165. Muggia F., Cannon T., Curtin J., Sarra T.
What is Inflammatory Breast Cancer? Revisiting the Case Definition. Cancers 2010; 2(1): 143-152. Levine PH, Zoflaghari L., Young H., Hafi M., Cannon T., Ganesen C., Veneroso C., Brem R., Sherman M.
Hairy Cell Leukemia: Current Concepts. Cancer Investigation 2008; 26:8 60-865. Cannon, T. Mobarek D., Wegge J., Tabbara I.
Immunotherapy: Cancer Care Gets Customized. October 11, 2017.
Colon Cancer in Young Adults: Know Your Risk. April 6, 2017.
David Bowie and Liver Cancer: Bringing Awareness to the Disease and Promising New Treatments on the Horizon. January 19, 2016.
Why Us and not the Elephants? November 5, 2015.
Supplements: Proceed with Caution. August 10, 2015.
Pharmacogenomics: Personalized Medicine in Action. August 3, 2015.
Drugs blocking tumor proteins offer hope for cancer outcomes. June 26, 2015.
Mixed Nuts with Mixed Results. June 24, 2015.
Medical EducationRutgers Medical School 2005
Training Specialty: Internal Medicine
6/23/2005 - 6/30/2008
Training Specialty: Hematology/Oncology
7/1/2008 - 7/1/2011